Considerations on an approach for establishing a framework for bioactive food components
Kathleen Ellwood1, Douglas A Balentine2, Johanna T Dwyer3
1College of Southern Maryland, La Plata, MD;
Advances in Nutrition (Bethesda, Md.)
|November 16, 2014
Summary
Establishing dietary recommendations for bioactive food components is challenging due to a lack of validated biomarkers. Further research is needed to refine intake guidelines for optimal health.
Area of Science:
- Nutritional Science
- Public Health
Background:
- Bioactive food components offer potential health benefits, but lack established intake recommendations like Dietary Reference Intakes (DRIs).
- Current DRIs for essential nutrients focus on deficiency prevention and chronic disease risk reduction.
Purpose of the Study:
- To highlight the challenges in establishing DRIs for nonessential bioactive food components.
- To discuss the need for validated biomarkers and improved methods for assessing intake.
Main Methods:
- Review of existing DRI frameworks and challenges for nonessential food components.
- Discussion of the role and limitations of biomarkers in setting intake recommendations.
Main Results:
- Validated biomarkers for disease risk reduction and intake assessment of bioactive compounds are largely lacking.
- Existing food-frequency questionnaires are inadequate for estimating nonessential component intake.
Conclusions:
- Refining the DRI process requires a framework for nonessential food components, incorporating intermediary biomarkers.
- Further research is crucial to validate biomarkers and establish reliable intake recommendations for bioactive food components.
Related Concept Videos
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
338
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
338
01:13Bioavailability: Overview
5.2K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
5.2K
01:17Bioavailability: Overview
782
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
782
01:23Factors Influencing Bioavailability: First-Pass Elimination
8.7K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
8.7K
01:22Bioavailability: Influencing Factors
644
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
644
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
516
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
516